SYNALAR 0.025 %
FLUOCINOLONE ACETONIDE : 0.025 % · DIN 02162512 · BAUSCH HEALTH, CANADA INC.
Health Canada status: DORMANT
What is SYNALAR?
SYNALAR 0.025 % contains FLUOCINOLONE ACETONIDE : 0.025 %. It is listed in the Health Canada Drug Product Database under DIN 02162512, held by BAUSCH HEALTH, CANADA INC., supplied as OINTMENT for TOPICAL administration. Health Canada currently lists it as dormant, status dated 28-Jul-2022. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02162512 |
|---|---|
| Brand name | SYNALAR |
| Generic / active ingredient | FLUOCINOLONE ACETONIDE : 0.025 % |
| Manufacturer | BAUSCH HEALTH, CANADA INC. |
| Strength | 0.025 % |
| Dosage form | OINTMENT |
| Route of administration | TOPICAL |
| Schedule | Prescription |
| ATC code | D07AC04 FLUOCINOLONE ACETONIDE |
| AHFS class | 84:06.00 |
| Biosimilar | No |
| Health Canada status | DORMANT |
| Status date | 28-Jul-2022 |
| Original market date | 1996-12-31 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02162512 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2162512 |
| Brand name | SYNALAR |
| Active ingredient / INN | FLUOCINOLONE ACETONIDE : 0.025 % |
| ATC code | D07AC04 |
| ATC anatomical main group | D — Dermatologicals |
| ATC therapeutic subgroup | D07 |
| AHFS class | 84:06.00 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | BAUSCH HEALTH, CANADA INC. |
Which pack is which?
| Strength on the label | 0.025 % |
|---|---|
| Dosage form | OINTMENT |
| Route | TOPICAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code D07AC04 FLUOCINOLONE ACETONIDE. 1 of 15 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| DERMA SMOOTHE/FS LIQ 0.01% | 0.01 % | EMULSION | HILL DERMACEUTICALS INC | MARKETED | DIN 00873292 |
| CAPEX | 0.01 % | SHAMPOO | GALDERMA CANADA INC | CANCELLED POST MARKET | DIN 02242738 |
| FLUODERM CRM 0.01% | .01 % | CREAM | TARO PHARMACEUTICALS INC | CANCELLED POST MARKET | DIN 00716782 |
| FLUODERM CRM 0.025% | .025 % | CREAM | TARO PHARMACEUTICALS INC | CANCELLED POST MARKET | DIN 00716790 |
| FLUODERM ONT 0.01% | .1 MG | OINTMENT | TARO PHARMACEUTICALS INC | CANCELLED POST MARKET | DIN 00716804 |
| FLUODERM ONT 0.025% | 0.25 MG | OINTMENT | TARO PHARMACEUTICALS INC | CANCELLED POST MARKET | DIN 00716812 |
| FS SHAMPOO-0.01% | .01 % | SHAMPOO | HILL DERMACEUTICALS INC | CANCELLED POST MARKET | DIN 02129078 |
| SYNALAR | 0.01 % | SOLUTION | BAUSCH HEALTH, CANADA INC. | CANCELLED POST MARKET | DIN 02162504 |
| SYNALAR CREAM 0.025% | 0.025 % | CREAM | MEDICIS CANADA LTD. | CANCELLED POST MARKET | DIN 00030422 |
| SYNALAR CREAM MILD 0.01% | 0.01 % | CREAM | MEDICIS CANADA LTD. | CANCELLED POST MARKET | DIN 00030414 |
Who else supplies FLUOCINOLONE ACETONIDE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. FLUOCINOLONE ACETONIDE appears in 4 registered pack listings across 3 markets, published on 3 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
This DIN is dormant — it holds a Health Canada authorization but is not currently being marketed in Canada, so it cannot simply be ordered from Canadian stock. Where a patient need exists, supply may be possible through exceptional importation or the Special Access Programme, subject to Health Canada's requirements and the prescriber's application. Nexara can advise on the route and on marketed alternatives.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.